BBLG
Bone Biologics
BBLG
BBLG
7 hedge funds and large institutions have $235K invested in Bone Biologics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
59% less capital invested
Capital invested by funds: $576K → $235K (-$341K)
Holders
7
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$11.4K | |
| 2 | +$11K | |
| 3 | +$8.05K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$444 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$96 |
Top Sellers
| 1 | -$72K | |
| 2 | -$38.3K | |
| 3 | -$17.6K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$15.5K |
| 5 |
VF
Virtu Financial
New York
|
-$3.35K |